Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Postoperative Hemorrhage D019106 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Klebsiella Infections D007710 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Conjunctivitis D003231 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Mucositis D052016 7 associated lipids
Bronchiectasis D001987 7 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lee YM et al. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893205
Hu L et al. Alkyl and alkoxycarbonyl derivatives of ginkgolide B: synthesis and biological evaluation of PAF inhibitory activity. 2000 Bioorg. Med. Chem. pmid:10896127
Parkman HP et al. The contractile action of platelet-activating factor on gallbladder smooth muscle. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10898747
Unno N et al. Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan. 2000 J. Vasc. Surg. pmid:10917985
Ruchaud-Sparagano MH et al. Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta 2-integrins. Role of tyrosine kinases and Ca2+ mobilization. 2000 J. Biol. Chem. pmid:10748085
Henderson WR et al. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model. 2000 J. Immunol. pmid:10706731
Zouki C et al. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. 2000 FASEB J. pmid:10698973
Hidi R et al. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. 2000 Eur. Respir. J. pmid:10706503
Chen LW et al. Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel. 2000 Shock pmid:10718373
Wang WJ et al. [Effects of musk glucoprotein on PAF production and cytosolic Ca2+ level in rat polymorphonuclear leukocytes in vitro]. 2000 Zhongguo Zhong Yao Za Zhi pmid:12525061
Manabe H et al. The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. 2000 Pulm Pharmacol Ther pmid:10718985
Tu W et al. [Influences of BN50739 on neutrophil elastase and phospholipase A2 in lung and tracheal mucosa of pigs with acute severe pancreatitis]. 2000 Zhonghua Jie He He Hu Xi Za Zhi pmid:11372382
Asai Y and Watanabe S Characterization of the physicochemical properties of the micelles by the novel platelet activating factor receptor antagonist E5880. 2000 Eur J Pharm Biopharm pmid:10799812
Partrick DA et al. Maximal human neutrophil priming for superoxide production and elastase release requires p38 mitogen-activated protein kinase activation. 2000 Arch Surg pmid:10668885
Cowling RT and Birnboim HC Expression of serum- and glucocorticoid-regulated kinase (sgk) mRNA is up-regulated by GM-CSF and other proinflammatory mediators in human granulocytes. 2000 J. Leukoc. Biol. pmid:10670586
Werr J et al. Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. 2000 Blood pmid:10688841
Bleeker WK et al. Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase. 2000 Blood pmid:10688848
Weintraub ST et al. Mass spectrometric analysis of platelet-activating factor after isolation by solid-phase extraction and direct derivatization with pentafluorobenzoic anhydride. 2000 J. Am. Soc. Mass Spectrom. pmid:10689672
Nilsson G et al. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. 2000 Immunology pmid:10692052
De Plaen IG et al. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. 2000 Br. J. Pharmacol. pmid:10694237
Wang WZ et al. Platelet-activating factor contributes to postischemic vasospasm. 2000 J. Surg. Res. pmid:10729242
Ishii S and Shimizu T Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. 2000 Prog. Lipid Res. pmid:10729607
Fukuyama S et al. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. 2000 Am. J. Respir. Crit. Care Med. pmid:10852755
Modschiedler K et al. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. 2000 Arch. Dermatol. Res. pmid:10664013
Hashimoto S et al. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells. 2000 Clin. Exp. Allergy pmid:10606930
Miike S et al. Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils. 2000 J. Leukoc. Biol. pmid:10648006
Dichmann S et al. Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils. 2000 Blood pmid:10648411
McManus LM and Pinckard RN PAF, a putative mediator of oral inflammation. 2000 Crit. Rev. Oral Biol. Med. pmid:12002818
Liao CH et al. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. 2000 J. Pharm. Pharmacol. pmid:10757426
Tokumura A et al. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. 2000 Biofactors pmid:11237195
Smith J et al. Differences in gene density on chicken macrochromosomes and microchromosomes. 2000 Anim. Genet. pmid:10782207
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Friedman E et al. Effect of hydrocortisone on platelet activating factor induced lung edema in isolated rabbit lungs. 2000 Respir Physiol pmid:10786645
Asai Y et al. A temperature study on critical micellization concentration of the novel platelet-activating factor receptor antagonist E5880 in water by electric conductivity measurements. 2000 Drug Dev Ind Pharm pmid:10789068
Balsinde J et al. Cellular regulation of cytosolic group IV phospholipase A2 by phosphatidylinositol bisphosphate levels. 2000 J. Immunol. pmid:10799904
Dearn S et al. Activation of platelet-activating factor (PAF) receptor stimulates nitric oxide (NO) release via protein kinase C-alpha in HEC-1B human endometrial epithelial cell line. 2000 Mol. Med. pmid:10803407
Kosaka T et al. Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity. 2000 Clin. Chim. Acta pmid:10807978
Triggiani M et al. Metabolism of lipid mediators in human eosinophils. 2000 Chem. Immunol. pmid:10761306
Rose F et al. E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893208
Emerson M et al. Characterization and functional significance of calcium transients in the 2-cell mouse embryo induced by an autocrine growth factor. 2000 J. Biol. Chem. pmid:10764773
Munakata M et al. Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure. 2000 Jpn. J. Thorac. Cardiovasc. Surg. pmid:10769990
Connolly AB and Vernon DR Manipulations of the metabolic response for management of patients with severe surgical illness: review. 2000 World J Surg pmid:10773122
Shindou H et al. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. 2000 Biochem. Biophys. Res. Commun. pmid:10814544
Mizutani Y et al. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. 2000 Biochim. Biophys. Acta pmid:10832103
Oshiro T et al. Characterization of platelet-activating factor-induced cytosolic calcium mobilization in human eosinophils. 2000 Clin. Exp. Allergy pmid:10792362
Hauser CJ et al. Major trauma enhances store-operated calcium influx in human neutrophils. 2000 J Trauma pmid:10780589
Kalia N et al. Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. 2000 Dig. Dis. Sci. pmid:10759248
Porta C et al. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. 2000 Haematologica pmid:10942928
Fraga AG et al. Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists. 2000 Eur J Pharm Sci pmid:11033071
Choi SY et al. Capsaicin inhibits platelet-activating factor-induced cytosolic Ca2+ rise and superoxide production. 2000 J. Immunol. pmid:11034409
Simon HU et al. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist. 2000 J. Immunol. pmid:11034418
Rowland BL et al. Elevated circulating concentrations of platelet activating factor in preeclampsia. 2000 Am. J. Obstet. Gynecol. pmid:11035340
Li N et al. Platelet-leukocyte cross talk in whole blood. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:11116075
Le Blanc K et al. Defective platelet aggregation in polycythaemia vera is not caused by impaired calcium signaling, phospholipase D activation or decreased amounts of focal adhesion proteins. 2000 Eur. J. Haematol. pmid:11092463
Iwamoto H et al. Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. 2000 Transplant. Proc. pmid:11119873
Hickey MJ et al. L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo. 2000 J. Immunol. pmid:11120848
Kaplan R et al. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease. 2000 Br. J. Haematol. pmid:11122160
Bussolati B et al. IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). 2000 Clin. Exp. Immunol. pmid:11122257
Denizot Y et al. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. 2000 Cytokine pmid:10857767
Kelly RF Current strategies in lung preservation. 2000 J. Lab. Clin. Med. pmid:11128744
Alloatti G et al. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. 2000 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11080081
Tjoelker LW and Stafforini DM Platelet-activating factor acetylhydrolases in health and disease. 2000 Biochim. Biophys. Acta pmid:11080681
Tanaka Y et al. Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats. 2000 Br. J. Pharmacol. pmid:11082118
Shibata K et al. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils. 2000 Prostaglandins Other Lipid Mediat. pmid:11060901
Dubois MJ and Vincent JL Clinically-oriented therapies in sepsis: a review. 2000 J. Endotoxin Res. pmid:11521072
Gastaldello K et al. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. 2000 Nephrol. Dial. Transplant. pmid:11007834
Wratten ML et al. Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins. 2000 Artif Organs pmid:11012537
Tokumura A et al. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. 2000 J. Lipid Res. pmid:10828088
Bailey SR et al. Differential activation of platelets from normal and allergic ponies by PAF and ADP. 2000 Inflamm. Res. pmid:10893045
Kobayashi Y et al. [Inhibitory effect of suplatast tosilate on eosinophil migration]. 2000 Arerugi pmid:10944827
Liu JK et al. Paeonilide, a novel anti-PAF-active monoterpenoid-derived metabolite from Paeonia delavayi. 2000 Biosci. Biotechnol. Biochem. pmid:10945272
Ueda T et al. Pancreatitis-associated ascitic fluid increases intracellular Ca(2+) concentration on hepatocytes. 2000 J. Surg. Res. pmid:10945960
Marathe GK et al. Bioactive phospholipid oxidation products. 2000 Free Radic. Biol. Med. pmid:10946218
Zhuang Q et al. Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes. 2000 J. Immunol. pmid:10946267
Davenpeck KL et al. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. 2000 J. Immunol. pmid:10946308
Martin M et al. [Antiretroviral ant anti-inflammatory properties of a novel platelet activation factor antagonist, PMS-601]. 2000 Pathol. Biol. pmid:10949851
Countryman NB et al. Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production. 2000 J. Invest. Dermatol. pmid:10951245
Soeki T et al. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. 2000 Jpn. Circ. J. pmid:10952148
Henig NR et al. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. 2000 Am. J. Respir. Crit. Care Med. pmid:10934081
Haribabu B et al. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. 2000 J. Exp. Med. pmid:10934231
Miyatake T et al. Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. 2000 Transplant. Proc. pmid:10936319
Wilks J The impact of the pill on implantation factors--new research findings. 2000 Ethics Med pmid:15015518
Dent G et al. Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. 2000 Immunology pmid:10886400
Montrucchio G et al. Role of platelet-activating factor in cardiovascular pathophysiology. 2000 Physiol. Rev. pmid:11015622
Taguchi R et al. Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry. 2000 J Mass Spectrom pmid:10972995
Clark GD et al. Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein. 2000 Neurochem. Res. pmid:10905621
Wang JH and Sun GY Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). 2000 Neurochem. Res. pmid:10905622
Baker RR Lipid acetylation reactions and the metabolism of platelet-activating factor. 2000 Neurochem. Res. pmid:10905630
Francescangeli E et al. Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex. 2000 Neurochem. Res. pmid:10905633
Viswanath M et al. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection. 2000 Pediatr. Res. pmid:10879808
Kusuhara H et al. Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells. 2000 Cytokine pmid:10880261
Tektonidou MG et al. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. 2000 Eur. J. Clin. Invest. pmid:10886305
Aihara M et al. Interaction between neurone and microglia mediated by platelet-activating factor. 2000 Genes Cells pmid:10886367
Kulikov VI and Muzya GI Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. 2000 Biochemistry Mosc. pmid:10810178
Folch E et al. H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. 2000 Free Radic. Biol. Med. pmid:10889459
Huo LJ and Yang ZM Effects of platelet activating factor on capacitation and acrosome reaction in mouse spermatozoa. 2000 Mol. Reprod. Dev. pmid:10862011
Cavallo-Perin P et al. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria. 2000 Nephrol. Dial. Transplant. pmid:10862637
Zhu W et al. Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs. 2000 Chin. Med. J. pmid:11776064
Wagner F et al. Ether lipids in the cell membrane of Mycoplasma fermentans. 2000 Eur. J. Biochem. pmid:11012682
Yildirim G et al. Does the platelet-activating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation. 2000 Biol Trace Elem Res pmid:11318001